APA

El Serafi M. M., El Khodary A. I., El Zawahry H. R., Mansour O. M. & Gaballa H. E. (20070925). Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. : Journal of the Egyptian National Cancer Institute.

Chicago

El Serafi Moustafa M, El Khodary Ahmed I, El Zawahry Heba R, Mansour Osman M and Gaballa Hussein E. 20070925. Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. : Journal of the Egyptian National Cancer Institute.

Harvard

El Serafi M. M., El Khodary A. I., El Zawahry H. R., Mansour O. M. and Gaballa H. E. (20070925). Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. : Journal of the Egyptian National Cancer Institute.

MLA

El Serafi Moustafa M, El Khodary Ahmed I, El Zawahry Heba R, Mansour Osman M and Gaballa Hussein E. Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study. : Journal of the Egyptian National Cancer Institute. 20070925.